AAPM 2026 Flash Talk Submission
Deadline to submit is November 17, 2025
Proposal Title
Speaker Name
First Name
Last Name
Credentials
Email
example@example.com
Organization
Address
Street Address
Street Address Line 2
City
State / Province
Postal / Zip Code
Phone Number
Please enter a valid phone number.
Title
Learning Objectives
Citations
Please attach your session description. 200 words or less, not including references.
Browse Files
Drag and drop files here
Choose a file
Cancel
of
About/Short Bio
Disclosures
Do any of the authors of this abstract have any commercial relationships to disclose? - If yes, please complete the Disclosure of Commercial Relationships.
Yes
No
Is any device or drug required FDA approval identified as an important component of your presentation? - If yes, please complete the FDA Disclosure Form.
Yes
No
Signature
Name
First Name
Last Name
Date
-
Month
-
Day
Year
Date
By submitting this session, the faculty certifies the following:
The identical session has not been submitted to any other meeting. Upon acceptance, the submitter accepts the commitment to present the session at AAPM PainConnect 2026.
Preferred Social Media
Please Select
LinkedIn
Twitter
Instagram
Facebook
Social Handle
Disclosure of Financial Relationships
All authors submitting abstracts for publications are required to disclose any relationships with industry that may direct bearing on relevant subject matter. The primary presenter must disclose any author/presenter who has relevant financial interest or other relationships occurring with the past 12 months with commercial companies or organizations.
Author Name
First Name
Last Name
Company
Company
Company
Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)
Additional Form if needed
Author Name
First Name
Last Name
Company
Company
Company
Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)
Additional Form if needed
Author Name
First Name
Last Name
Company
Company
Company
Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)
Additional Form if needed
Author Name
First Name
Last Name
Company
Company
Company
Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)
Collapse Stopper
FDA Disclosure
If a device or drug requiring FDA approval is identified as an important component of your presentation, please list the device/drug and indicate the FDA status as either: Approved, Investigational Device/Drug, Not approved for distribution in the United States.
Device/Drug
blanks
Status
blank
Device/Drug
blanks
Status
blank
Device/Drug
blanks
Status
blank
Device/Drug
blanks
Status
blank
Device/Drug
blanks
Status
blank
Device/Drug
blanks
Status
blank
Submit
Should be Empty: